N-Fmoc-4-methyl-L-tryptophan is an indole-modified amino acid with altered aromatic electronics and steric influence. The residue supports studies on fluorescence behavior, stacking interactions, and conformational restriction. Researchers employ it in constructing aromatic-rich peptide domains. Its Fmoc protection ensures compatibility with solid-phase synthesis.
CAT No: R2136
CAS No:2411871-30-0
Synonyms/Alias:N-Fmoc-4-methyl-L-tryptophan;2411871-30-0;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-methyl-L-tryptophan;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-methyl-1H-indol-3-yl)propanoic acid;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-3-(4-methyl-1H-indol-3-yl)propanoic acid;MFCD01632012;CS-0439393;F79872;
1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More